• Tue news: Regeneron fails to block Eylea biosimilar. Inside the GLP-1 price war. Novartis inks $1B biobucks deal. UCB/Biogen lupus drug. Lilly Alzheimer’s drug approved in Japan. See more on our front page

OlivJasn

new user
Messages
2
Reaction score
0
Points
1

Profile posts Latest activity Postings About

  • There are no messages on OlivJasn's profile yet.
  • Loading…
  • Loading…
  • Loading…
Top Bottom
Back